ArticleWorld journal of gastrointestinal oncology2023

Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy.

Huttakan Navadurong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.